Johanna Mercier

Executive Vice President, Chief Commercial Officer at Gilead Sciences, Inc.

Johanna Mercier

Johanna Mercier

Executive Vice President, Chief Commercial Officer at Gilead Sciences, Inc.

Biography

Ms. Mercier leads the company’s Commercial organization with responsibility for commercializing Gilead’s therapies in countries and regions around the world.

Prior to joining Gilead in July 2019, Johanna spent 25 years at Bristol-Myers Squibb, where she was most recently President and Head of U.S., France, Germany, Japan, Korea and Taiwan. In her role, she oversaw a complex organization comprising a majority of the company’s business. Ms. Mercier was also actively engaged with the policy and advocacy community to ensure the affordability and access of prescription medicines to patients.

Ms. Mercier began her career in sales and marketing in Canada, then went on to lead worldwide early and clinical portfolios, followed by market teams across both the U.S. and Europe. She was Bristol-Myers Squibb’s General Manager of UK & Ireland and later President of Worldwide Markets for Europe, Australia and Canada. In her most recent role, which included responsibility for the U.S. business and other priority markets, she successfully evolved the culture and drove strong commercial execution with double-digit growth and multiple launches that changed the standard of care in melanoma and renal cancers.

Ms. Mercier holds a science degree from the University of Montreal and an MBA from Concordia University.

Overview
RelSci Relationships

1356

Number of Boards

1

Relationships
RelSci Relationships are individuals Johanna Mercier likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Executive Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Director & Assistant Secretary at Gilead Sciences, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Co-Founder at Permeon Biologics, Inc.

Relationship likelihood: Strong

Executive Vice President, Global Commercial Operations at Amgen, Inc.

Relationship likelihood: Strong

President, Director at Gilead Pharmasset LLC

Relationship likelihood: Strong

General Manager at Gilead Sciences, Inc.

Relationship likelihood: Strong

Partner at Gilead Sciences, Inc.

Relationship likelihood: Strong

Paths to Johanna Mercier
Potential Connections via
Relationship Science
You
Johanna Mercier
Executive Vice President, Chief Commercial Officer at Gilead Sciences, Inc.
Education

Concordia University (commonly referred to as Concordia) is a public comprehensive university located in Montreal, Quebec, Canada. Founded in 1974 following the merger of Loyola College and Sir George Williams University, Concordia is one of the three universities in Quebec where English is the primary language of instruction.

The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

Career History
Executive Vice President, Chief Commercial Officer
2019 - Current

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

General Manager for the United Kingdom & Ireland
2014 - 2019

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Other Affiliations

Johanna Mercier is affiliated with Gilead Sciences, Inc., Bristol-Myers Squibb Company

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Johanna Mercier. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Johanna Mercier's profile does not indicate a business or promotional relationship of any kind between RelSci and Johanna Mercier.